Lisa B. Leypoldt, Varun Raj Ginde, Britta Besemer, Marc S. Raab, Mathias Haenel, Christoph Mann, Christian Michel, Hans Christian Reinhardt, Yon-Dschun Ko, Igor W. Blau, Christof Scheid, Maike de Wit, Martin Görner, Peter Staib, Hermann Einsele, Michael Hundemer, Axel Benner, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C. Weisel. "Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) for high-risk (HR) newly diagnosed multiple myeloma (NDMM): First-time report of the full cohort of transplant-eligible (TE) patients in the GMMG-CONCEPT trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7509